The FDA's fast track designation aims to expedite ITM-94's development for diagnosing clear cell renal cell carcinoma. The ...

Kidney cancer happens when cells in one or both kidneys start to grow out of control. Eventually, the cells become a mass called a tumor. As the cancer progresses, it can spread to other parts of the ...

ITM-94 forms a theranostic pair with therapeutic candidate ITM-91, targeting carbonic anhydrase IX (CAIX) in clear cell renal ...

DPI-4452 targets CAIX in tumors, offering noninvasive diagnostic potential for ccRCC with favorable tolerability. The agent is part of a theranostic pair wi ...

How Does Keytruda Work for RCC? Some cancer cells have what are called checkpoint proteins known as PD-L1 on their cell surface. Some immune cells in our bodies called T cells have proteins on their ...

During a live event, Moshe C. Ornstein, MD, MA, considered the trial design and outcomes of 2 trials of combination regimens ...

TKI-based regimens remain the primary approach for metastatic renal cell carcinoma after immune checkpoint inhibitor therapy, ...

Planned treatment "holidays" can help lessen the toxicity burden of tyrosine kinase inhibitors (TKIs) for selected patients ...

A specialist in treating kidney cancer patients explained why the rare cancer struck someone at such a young age.

The lead singer of the band 3 Doors Down shared Wednesday that he has stage 4 kidney cancer that has spread to his lung. In an Instagram video, Brad Arnold said he had been feeling sick for a few ...

Results of CheckMate 67T, a phase 3 noninferiority study comparing subcutaneous and intravenous nivolumab formulations in RCC, were presented at JADPRO 2025.